Welcome to the HeartFlow, Inc. (“HeartFlow”) website at www.heartflow.com (or any successor URLs thereof) (collectively, the “Site”). HeartFlow values your privacy and the privacy of visitors of the Site (referred to individually as “Customer” and collectively as“Customers“).
Customer-provided Information: You may provide to HeartFlow what is generally called “personally identifiable” information (such as your name, email address, postal mailing address, and telephone number) when using the Site.
“Cookies” Information: When you visit the Site, we may send one or more cookies – small text files containing a string of alphanumeric characters – to your computer. HeartFlow uses only session cookies. A session cookie disappears after you close your browser.
To manage the cookies and similar technologies used (tracking pixels, web beacons, etc.) and related consents, we use the consent tool “Real Cookie Banner”. Details on how “Real Cookie Banner” works can be found at https://devowl.io/rcb/data-processing/.
“Automatically Collected” Information. When you visit the Site, we may automatically record certain information from your web browser by using different types of technology, including “clear gifs” or “web beacons.” This “automatically collected” information may include Internet Protocol address (“IP Address“), web browser type, the web pages or sites that you visit just before or just after the Site, the pages you view on the Site, and the dates and times that you visit the Site.
HeartFlow uses the information you provide or that we collect to operate, maintain, enhance, and provide all of the features, information, and services found on the Site.
HeartFlow may also use the information you provide to contact you to further discuss your interest in our company, in the HeartFlow Services, and to send information regarding our company or partners, such as promotions and events.
HeartFlow uses all of the information that we collect to understand and analyze the usage trends and preferences of our Customers, to improve the way the Site works and looks, and to create new features and functionality.
HeartFlow may use “automatically collected” information and “cookies” information to: (a) remember your information so that you will not have to re-enter it during your visit or the next time you visit the Site, and (b) monitor aggregate site usage metrics such as the total number of visitors and pages viewed.
HeartFlow does not share your personally identifiable information with other organizations for their marketing or promotional uses without your express consent.
HeartFlow may disclose automatically collected and other aggregate non-personally identifiable information with interested third parties to assist such parties in understanding the usage, viewing, and demographic patterns for certain programs, content, services, advertisements, promotions, and/or functionality found on the Site.
HeartFlow may also disclose Customer information if required to do so by law or in the good-faith belief that such action is necessary to comply with local, state, or federal laws, or respond to a court order, judicial or other government subpoena, or warrant. In some cases, we may make such disclosures without first providing notice to Customers.
HeartFlow also reserves the right to disclose Customer information that we believe, in good faith, is appropriate or necessary to take precautions against liability; protect HeartFlow from fraudulent, abusive, or unlawful uses; to investigate and defend ourselves against any third party claims or allegations; to assist government enforcement agencies; to protect the security or integrity of the Site; or to protect the rights, property, or personal safety of HeartFlow, our Customers, or other related or affected third parties.
You may, of course, decline to share your personally identifiable information with HeartFlow, in which case HeartFlow will not be able to provide to you some of the features and functionality found on the Site.
Protecting the privacy of young children is especially important. For that reason, HeartFlow does not knowingly collect or maintain personally identifiable information on the Site from persons under 13-years-of-age, and no part of the Site is directed to persons under 13. If HeartFlow learns that personally identifiable information of persons less than 13-years-of-age has been collected by HeartFlow without verifiable parental consent, then HeartFlow will take the appropriate steps to delete this information.
HeartFlow uses commercially reasonable physical, managerial, and technical safeguards to preserve the integrity and security of your personal information. We cannot, however, ensure or warrant the security of any information you transmit to HeartFlow, and you do so at your own risk. Once we receive your transmission of information, HeartFlow makes commercially reasonable efforts to ensure the security of our systems. However, please note that this is not a guarantee that such information may not be accessed, disclosed, altered, or destroyed by breach of any of our physical, technical, or managerial safeguards.
If HeartFlow learns of a security systems breach, then we will attempt to notify you using the contact information that you may have provided so that you can take appropriate protective steps. HeartFlow may post a notice on the Site if a security breach occurs. Depending on where you live, you may have a legal right to receive notice of a security breach in writing. To receive a free written notice of a security breach you should notify us at firstname.lastname@example.org.
The Site is hosted in the United States. If you nonetheless choose to use the Site from the European Union or other regions of the world with laws governing data collection and use that may differ from U.S. law, then please note that you may be transferring your personally identifiable information outside of those regions to the United States and by providing your personally identifiable information on the Site you consent to that transfer.
In the event that HeartFlow is acquired by or merged with a third-party entity, we reserve the right, in any of these circumstances, to transfer or assign the information that we have collected from Customers as part of such merger, acquisition, sale, reincorporation, reorganization, or other change of control.
If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.
HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用することを目的としています。
さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.
The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.
For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.
Please apply for research grants through our online submission form.
Executive Vice President and Chief Medical Officer
Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.
He received his A.B. from Harvard College and his M.D. from Harvard Medical School.